Windlas Biotech Ltd - 543329 - Statement Of Deviation For The Quarter Ended June 30, 2022
Statement of deviation for the quarter ended June 30, 202204-08-2022
04-08-2022
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation on Q1(FY23) un-audited financial results04-08-2022
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
press release on un-audited Standalone and Consolidated Financial Results for the Quarter ended June 30, 202204-08-2022
Windlas Biotech Ltd - 543329 - Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2022
Un-audited Standalone and Consolidated Financial Results for the Quarter ended June 30, 202204-08-2022
Windlas Biotech Ltd - 543329 - Board Meeting Outcome for Approval Of Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2022
Approval of Un-audited Standalone and Consolidated Financial Results for the Quarter ended June 30, 202204-08-2022
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Monitoring Agency Report for the Quarter ended June 30, 202226-07-2022
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Conference Call to discuss financial performance for quarter ended June 30, 2022.26-07-2022
Windlas Biotech Ltd - 543329 - Board Meeting Intimation for To Consider And Approve The Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2022
Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2022 ,inter alia, to consider and approve to consider and approve the un-audited standalone and consolidated financial results for the quarter ended June 30, 202225-07-2022
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.20-07-2022
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 201514-07-2022